In the ever-evolving world of regenerative medicine, stem cell therapy is offering renewed hope to patients with chronic conditions, degenerative diseases, and even cosmetic concerns. As treatments become more refined, the science behind them continues to evolve. Among the most important elements in stem cell science are cell surface markers and CD90, also known as Thy-1, is one of the most crucial markers for assessing stem cell potency, especially in mesenchymal stem cell (MSC stem cell) therapies.
What is CD90?
CD90 is a glycoprotein found on the surface of mesenchymal stem cells and other cell types such as neurons, endothelial cells, and fibroblasts. In the context of regenerative medicine, CD90 serves as one of the three standard markers required by the International Society for Cellular Therapy (ISCT) to identify MSC stem cell, alongside CD73 and CD105.
This marker plays a significant role in cell adhesion, migration, differentiation, and signaling, making it essential in ensuring the effectiveness of stem cell-based therapies.
The Importance of CD90 in Stem Cell Therapy
- Identification of True MSC stem cell
To ensure that a cell population used in treatment is truly mesenchymal stem cells, it must express CD90. Cells that do not express this marker may not possess the regenerative abilities required for successful therapy. At Vega Medical Services, all cell batches undergo strict flow cytometry testing to verify CD90 expression as part of our comprehensive quality assurance protocol.
- Enhanced Cellular Adhesion and Migration
CD90-positive stem cells have superior abilities to adhere to tissues and migrate to damaged sites. This is critical in orthopedic treatments, where stem cell must travel to inflamed or deteriorating joints, as well as in cosmetic applications, where skin regeneration relies on accurate cell targeting.
- Support for Tissue Regeneration
Research shows that CD90 expression enhances the ability of MSC stem cell to support angiogenesis (formation of new blood vessels), cartilage formation, and wound healing. These functions are pivotal in treatments for osteoarthritis, sports injuries, and chronic wounds.
- Immunomodulatory Activity
CD90 is linked to anti-inflammatory responses and immune system regulation. Cells expressing CD90 play a key role in modulating immune reactions, making them valuable for autoimmune conditions and inflammatory diseases.
Fresh Cells and the CD90 Advantage
Freshly prepared stem cells retain higher marker expression levels, including CD90, compared to frozen or long-stored cells. At Vega Medical Services, we prioritize the use of fresh, high-viability cells that undergo rigorous testing to ensure optimal CD90 expression.
Our clinical protocols include:
- Flow Cytometry Analysis for CD90, CD73, and CD105
- Viability and Potency Testing
- GMP-compliant cell processing for international-grade safety and sterility
Custom-Tailored Treatments Backed by CD90 Testing
Whether you’re undergoing stem cell therapy for orthopedic recovery, anti-aging, or chronic disease management, CD90 plays a vital role in your treatment’s success. Our specialists at Vega Medical Services analyze each batch of cells for CD90 expression to ensure compatibility with your personalized care plan.
This approach leads to:
- Better tissue integration
- Faster recovery timelines
- Reduced inflammation
- Improved long-term results
Why CD90 Testing Sets Vega Apart
In an industry where outcomes matter, Vega Medical Services stands out by ensuring every stem cell batch is assessed for the most important markers. CD90 testing is not an afterthought it is central to our promise of safe, effective, and transparent regenerative medicine.
Our robust quality assurance includes:
- Sterility Testing
- Marker Profile Reporting
- Real-Time Data Sharing with Patients
- Cell Source Traceability
The Future of Stem Cell Medicine with CD90
As regenerative therapies evolve, molecular markers like CD90 are playing a growing role in personalizing treatments and improving clinical outcomes. With more clinical trials incorporating CD90-based protocols, it may soon become a standard biomarker not just for MSC stem cell identification but also for predicting treatment efficacy.
Additionally, the role of CD90 in exosome production and EV-based therapies is being explored, providing yet another reason to focus on this marker.
Final Thoughts
In stem cell therapy, the details matter. Markers like CD90 aren’t just scientific jargon they are real indicators of treatment quality, safety, and effectiveness. At Vega Medical Services, we use CD90 as a cornerstone for delivering trusted, science-driven care to patients seeking regenerative solutions.
Whether you are exploring anti-aging therapies, immune modulation, or orthopedic recovery, insist on stem cell treatments that prioritize quality. Insist on CD90. And let Vega Medical Services help you on your journey toward healing and rejuvenation through the power of precision regenerative medicine.